EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Biological Evaluation of 5‐Arylpyrazoles as Potential MCT 1 Inhibitors Targeting Lactate Transport

Irina P Fonareva iD, Elena V Svirshchevskaya iD, Elena V Mitroshina iD, Ekaterina A Marasanova, Maria V Vedunova, Elena A Zaburdaeva, Alexey Yu Fedorov iD, Ekaterina S Shchegravina iD

ChemMedChem · 28.10.2026 · 21 (20)

DOI: 10.1002/cmdc.70555 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 26.10.2026. Verfasst von Irina P Fonareva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Nizhny Novgorod State University, Nizhny Novgorod, Russian Federation. Hauptthemen laut MEDLINE: Monocarboxylic Acid Transporters, Pyrazoles, Symporters, Lactic Acid. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monocarboxylate transporter 1 (MCT1) represents an attractive therapeutic target as an important regulator of tumor metabolism. In this study, we developed a convenient synthetic approach to novel 5‐arylpyrazole derivatives as potential MCT1 inhibitors. Eleven new pyrazole derivatives ( 17a–k ) were prepared through a six‐step sequence in 5%–19% overall yields. Screening using 3‐bromopyruvate assays revealed that compound 17c, bearing a 3‐fluorophenyl substituent, significantly inhibited MCT1‐mediated transport at below its cytotoxic concentrations. The compound 17c induced dose‐ and time‐dependent accumulation of intracellular lactate in multiple cell lines, confirming its ability to interfere with MCT1‐driven metabolism. These results identify 5‐arylpyrazoles as a promising chemotype of MCT1 inhibitors, and highlight compound 17c as a potential lead for further optimizations in cancer metabolism‐targeted therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monocarboxylic Acid TransportersPyrazolesSymportersLactic AcidAntineoplastic AgentsMonocarboxylate Transport Protein 1HumansStructure-Activity RelationshipMolecular StructureCell Line, TumorDose-Response Relationship, DrugBiological Transport

Stichwörter der Autor:innen

MCT1 inhibitorsgliomapyrazole derivativestumor lactate metabolism

Substanzen

Monocarboxylic Acid TransportersPyrazolesMonocarboxylate Transport Protein 1SymportersLactic AcidAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Organic Chemistry, Nizhny Novgorod State University, Nizhny Novgorod, Russian Federation.
  • Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, Moscow, Russian Federation.
  • Institute of biology and biomedicine, Nizhny Novgorod State University, Nizhny Novgorod, Russian Federation.

ORCID-Profile: Irina P Fonareva, Elena V Svirshchevskaya, Elena V Mitroshina, Alexey Yu Fedorov, Ekaterina S Shchegravina

Förderung

  • Russian Science Foundation

Zitieren

APA

Fonareva, I. P., Svirshchevskaya, E. V., Mitroshina, E. V., Marasanova, E. A., Vedunova, M. V., Zaburdaeva, E. A., Fedorov, A. Y., & Shchegravina, E. S. (2026). Synthesis and Biological Evaluation of 5‐Arylpyrazoles as Potential MCT 1 Inhibitors Targeting Lactate Transport. ChemMedChem, 21(20). https://doi.org/10.1002/cmdc.70555

Vancouver

Fonareva IP, Svirshchevskaya EV, Mitroshina EV, Marasanova EA, Vedunova MV, Zaburdaeva EA, et al. Synthesis and Biological Evaluation of 5‐Arylpyrazoles as Potential MCT 1 Inhibitors Targeting Lactate Transport. ChemMedChem. 2026;21(20). doi:10.1002/cmdc.70555

BibTeX
@article{Fonareva2026,
  author = {Fonareva, Irina P and Svirshchevskaya, Elena V and Mitroshina, Elena V and Marasanova, Ekaterina A and Vedunova, Maria V and Zaburdaeva, Elena A and Fedorov, Alexey Yu and Shchegravina, Ekaterina S},
  title = {Synthesis and Biological Evaluation of 5‐Arylpyrazoles as Potential MCT 1 Inhibitors Targeting Lactate Transport},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {20},
  doi = {10.1002/cmdc.70555}
}
Kostenlos starten →